📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
5paisa Capital Announces ₹468.82 Crore Rights Issue at ₹300 Per Share; Ratio 1:2
5paisa Capital Limited has filed its Letter of Offer for a rights issue aiming to raise up to ₹4,688.23 million. The company will issue 15,627,419 equity shares at a price of ₹300 per share, which includes a ₹290 premium. Eligible shareholders as of the record date, March 17, 2026, can subscribe to 1 new share for every 2 shares held. The issue is scheduled to open on March 27, 2026, and close on April 10, 2026.
Key Highlights
Total fundraise of up to ₹4,688.23 million through the issuance of 1.56 crore shares
Rights entitlement ratio set at 1:2 for shareholders holding stock on March 17, 2026
Issue price fixed at ₹300 per share, significantly above the face value of ₹10
On-market renunciation period for Rights Entitlements ends on April 07, 2026
Expected listing date for the new Rights Equity Shares is April 16, 2026
💼 Action for Investors
Investors should evaluate the ₹300 issue price against the prevailing market price to determine the attractiveness of the offer. If not participating, shareholders should ensure they sell their Rights Entitlements (REs) during the trading window to avoid value dilution.
5Paisa Capital to Raise ₹468.82 Cr via 1:2 Rights Issue at ₹300/Share; Record Date March 17
5Paisa Capital Limited has finalized terms for a Rights Issue worth ₹4,688.23 million. The company will issue 15,627,419 shares at a price of ₹300 each, representing a 1:2 ratio for existing shareholders. The record date to determine eligibility is March 17, 2026, with the subscription period running from March 27 to April 10, 2026. This move will expand the total outstanding equity shares from 31.25 million to 46.88 million upon full subscription.
Key Highlights
Rights Issue size of ₹4,688.23 million at an issue price of ₹300 per share.
Rights Entitlement Ratio set at 1:2 (one new share for every two shares held).
Record date for eligibility is March 17, 2026; Issue period is March 27 to April 10, 2026.
Total equity shares to increase by 50% from 31.25 million to 46.88 million shares.
On-market renunciation period for Rights Entitlements ends on April 07, 2026.
💼 Action for Investors
Shareholders should compare the ₹300 issue price with the prevailing market price to determine if they should subscribe or sell their rights entitlements. Ensure shares are in the demat account by the March 17 record date to be eligible.
5Paisa Capital Announces ₹468.8 Cr Rights Issue at ₹300 per Share; Ratio 1:2
5Paisa Capital has approved a rights issue to raise approximately ₹468.82 crore by issuing 1.56 crore equity shares. Existing shareholders as of the record date of March 17, 2026, are eligible to subscribe to one new share for every two shares held. The issue price is set at ₹300 per share, which is payable in full upon application. This capital infusion is intended to strengthen the company's capital base and support its growth initiatives in the discount brokerage sector.
Key Highlights
Rights Issue size of up to ₹4,688.23 million through the issuance of 15,627,419 shares
Entitlement ratio fixed at 1:2 (one rights share for every two shares held)
Issue price set at ₹300 per share, including a premium of ₹290 per share
Record date for eligibility is March 17, 2026, with the issue opening on March 27, 2026
Post-issue equity base to expand from 31.25 million to 46.88 million shares assuming full subscription
💼 Action for Investors
Investors should compare the ₹300 issue price with the current market price to determine the benefit of subscribing. Those not intending to subscribe should sell their rights entitlements during the renunciation period (March 27 to April 7) to prevent value loss from dilution.
5Paisa Capital Closes Trading Window Ahead of Rights Issue Terms Determination
5Paisa Capital Limited has announced the closure of its trading window for all designated persons starting February 27, 2026. This regulatory step is taken as the company's Board of Directors or Rights Issue Committee prepares to finalize the specific terms of a proposed Rights Issue. The committee will determine critical details including the issue price, rights entitlement ratio, and the record date for shareholders. The trading window will remain closed until 48 hours after these details are formally disclosed to the stock exchanges.
Key Highlights
Trading window closed for all Designated Persons and Promoters effective from February 27, 2026.
Closure is in anticipation of a Board/Committee meeting to finalize Rights Issue terms.
Pending decisions include the issue price, rights entitlement ratio, and the official record date.
The window will reopen 48 hours after the announcement of the Board's decision on the fundraise.
💼 Action for Investors
Investors should wait for the specific announcement regarding the Rights Issue price and ratio to evaluate the cost of participation and potential equity dilution. Monitor the record date to ensure eligibility if the terms are favorable.
5Paisa Capital Receives SEBI Research Analyst Registration for 5-Year Term
5Paisa Capital Limited has been granted a Certificate of Registration as a Research Analyst by SEBI, effective from February 26, 2026. This license is valid for a period of five years, subject to renewal fees as per SEBI regulations. The registration allows the company to formally provide research reports and investment recommendations to its clients. This move is expected to strengthen its service offerings and potentially increase its value proposition in the competitive discount brokerage space.
Key Highlights
SEBI granted the Research Analyst registration via email on February 26, 2026
The license is valid for a period of 5 years from the date of grant
Enables the company to undertake research activities under SEBI (Research Analysts) Regulations, 2014
The registration is expected to support and expand the company's existing business operations
💼 Action for Investors
This is a positive development that enhances 5Paisa's service portfolio and competitive edge. Investors should monitor how this impacts client acquisition and engagement in the upcoming quarters.
5Paisa Capital Board Approves Rights Issue Up To Rs 4,750 Million
5Paisa Capital's Board of Directors has approved a proposal to raise capital through a Rights Issue of equity shares. The total amount to be raised is capped at Rs 4,750 million (Rs 475 crore). This capital infusion is likely intended to strengthen the company's balance sheet and support growth initiatives in the competitive discount brokerage space. Specific details regarding the issue price, entitlement ratio, and record date will be finalized by a newly formed Rights Issue Committee.
Key Highlights
Board approved fundraising via Rights Issue not exceeding Rs 4,750 million
The issue involves fully paid-up equity shares with a face value of Rs 10 each
A dedicated Rights Issue Committee has been constituted to finalize pricing and ratio
Record date and timing of the issue will be notified subsequently
💼 Action for Investors
Existing shareholders should monitor for the announcement of the record date and the rights entitlement ratio. The pricing discount relative to the current market price will determine the attractiveness of participating in the issue.
5paisa Capital Board Approves Fund Raising Up To Rs. 500 Crores
The Board of Directors of 5paisa Capital has approved a significant capital infusion plan to raise up to Rs. 500 crores. The funds may be raised through various instruments including equity shares, convertible securities, QIPs, or rights issues. This move is aimed at strengthening the company's capital base to support its growth objectives in the competitive discount brokerage market. Specific details regarding the issue price and timing will be finalized at a later stage, subject to shareholder and regulatory approvals.
Key Highlights
Board approved fund raising for an aggregate amount not exceeding Rs. 500 crores
Fundraising modes include QIP, Rights Issue, Preferential Issue, or Private Placement
The proposal is subject to necessary shareholder and regulatory approvals
Detailed terms including pricing and timing to be determined by the Board at a subsequent stage
💼 Action for Investors
Investors should watch for the specific mode of fundraising and the issue price to assess potential equity dilution. The capital raise is a positive signal for the company's expansion plans and competitive positioning.
5Paisa Capital Q3FY26 PAT Surges 30% QoQ to ₹12.3 Cr; Revenue Up 3% to ₹79.4 Cr
5Paisa Capital reported a strong Q3FY26 performance with Profit After Tax (PAT) growing 30% QoQ to ₹12.3 crore, achieving a PAT margin of 16%. Total revenue increased by 3% QoQ to ₹79.4 crore, supported by a 7% rise in broking revenue and a 24% surge in notional ADTO to ₹3.31 trillion. The company added 78,000 new customers, bringing the total base to 5.08 million, while focusing on high-quality acquisitions and improved lifetime value. Despite a one-time ₹62.20 lakh hit from new labor laws, the company maintained operational efficiency and saw its Mutual Fund AUM grow 13% to ₹1,868 crore.
Key Highlights
Profit After Tax (PAT) increased 30% QoQ to ₹12.3 crore with a 16% margin.
Notional Average Daily Turnover (ADTO) grew robustly by 24% QoQ to ₹3.31 trillion.
Total customer base reached 5.08 million with 78,000 new acquisitions during the quarter.
Mutual Fund AUM grew 13% QoQ to ₹1,868 crore, while the MTF book stood at ₹379 crore.
Broking revenue rose 7% QoQ to ₹37.1 crore, reflecting improved retail participation.
💼 Action for Investors
Investors should view the strong PAT growth and expansion in ADTO as positive indicators of the company's ability to monetize its platform effectively. Monitor the continued growth of the Margin Trade Funding (MTF) book and the impact of technology enhancements on customer retention.
5Paisa Capital Appoints Three Senior Leaders in HR, Product, and Design Functions
5Paisa Capital has announced the appointment of three key Senior Managerial Personnels (SMPs) effective January 14, 2026, to bolster its leadership team. Ms. Geetha Menon joins as Head of HR with over 20 years of experience, while Mr. Abhinav Agarwal, with 13 years in digital product strategy, takes over as Head of Investing Product. Additionally, Mr. Dinesh Singh, a design veteran with 19+ years of experience including a stint as Head of Design at Paytm, joins as Head of Design. These appointments signal a strategic focus on enhancing digital product capabilities and organizational culture to drive future growth in the competitive fintech space.
Key Highlights
Ms. Geetha Menon appointed as Head of HR, bringing 20+ years of experience from IIFL Capital and IT sectors
Mr. Abhinav Agarwal joins as Head of Investing Product with 13 years of expertise from Motilal Oswal and INDMoney
Mr. Dinesh Singh, with 19+ years of experience and former Head of Design at Paytm, appointed as Head of Design
All three appointments are effective from January 14, 2026, and designated as Senior Managerial Personnels (SMPs)
💼 Action for Investors
Investors should view these high-caliber hires from established fintech and financial firms as a positive step toward improving product innovation and user experience. Monitor the platform's user growth and product rollout efficiency in the coming quarters to gauge the impact of this new leadership.
5Paisa Capital Appoints Three Senior Leaders to Strengthen Product and Design Teams
5Paisa Capital has announced the appointment of three Senior Managerial Personnels (SMPs) effective January 14, 2026, to bolster its leadership in product and design. The new hires include Dinesh Singh as Head of Design, who brings 19+ years of experience from Paytm and Freshworks, and Abhinav Agarwal as Head of Investing Product with 13 years of expertise in digital product strategy. Additionally, Geetha Menon joins as Head of HR with over 20 years of experience in the financial services sector. These strategic appointments are aimed at driving digital transformation and enhancing the user experience of the 5Paisa platform.
Key Highlights
Dinesh Singh appointed as Head of Design with 19+ years of experience, including a pivotal role in building the Paytm ecosystem.
Abhinav Agarwal joins as Head of Investing Product with 13 years of experience from Motilal Oswal, INDMoney, and HDFC Bank.
Geetha Menon appointed as Head of HR, bringing over 20 years of experience from IIFL Capital and IT services.
All three appointments are effective from January 14, 2026, and are designated as Senior Managerial Personnels (SMPs).
💼 Action for Investors
Investors should view these high-caliber hires as a positive move to improve the company's digital competitiveness and product innovation. Monitor if these leadership changes lead to improved platform engagement and market share growth in the discount brokerage space.
5paisa Capital Q3FY26 PAT Surges 30% QoQ to ₹12.3 Cr; Income Up 3%
5paisa Capital reported a strong sequential recovery in Q3FY26, with Profit After Tax (PAT) rising 30% QoQ to ₹12.3 crore. While quarterly income grew 3% QoQ to ₹79.3 crore, the year-on-year performance remains under pressure with a 24% decline in PAT compared to Q3FY25. The company added 0.78 lakh new clients, reaching a total base of 50.8 lakhs, and saw a significant 24% QoQ growth in Average Daily Turnover (ADTO). Management highlighted cost optimization and technology investments as key drivers for the improved quarterly margins of 15%.
Key Highlights
Consolidated PAT grew 30% QoQ to ₹12.3 Cr, though it fell 24% YoY from ₹16.2 Cr.
Total income for Q3FY26 stood at ₹79.3 Cr, a 3% increase sequentially but a 7% drop YoY.
Average Daily Turnover (ADTO) increased by 24% QoQ, supported by record market highs.
Operating expenses decreased by 3% QoQ, contributing to a healthy PAT margin of 15%.
Nine-month (9MFY26) PAT of ₹33.4 Cr shows a sharp 43% decline compared to the previous year.
💼 Action for Investors
Investors should note the strong sequential recovery and cost control measures, but remain cautious due to the significant year-on-year decline in profitability. Monitor if the growth in ADTO and MTF book can be sustained to offset the overall 9-month earnings drag.
5paisa Capital Q3FY26 PAT Surges 30% QoQ to ₹123 Mn; ADTO Up 24%
5paisa Capital reported a strong recovery in profitability for Q3FY26, with PAT growing 30% QoQ to ₹123 million despite a challenging regulatory environment. Revenue grew 3% QoQ to ₹793 million, supported by a 24% increase in Average Daily Turnover (ADTO) to ₹3.31 trillion. While new customer acquisition slowed by 18% QoQ to 78,000, the total customer base reached 5.08 million. The company's focus on high-yield products is evident in the 13% growth of Mutual Fund AUM and a steady expansion of the Margin Trade Funding (MTF) book to ₹3,791 million.
Key Highlights
Profit After Tax (PAT) increased significantly by 30% QoQ to ₹123 million.
Average Daily Turnover (ADTO) rose 24% QoQ to ₹3.31 trillion, driven by derivatives.
Mutual Fund AUM grew 13% QoQ to reach ₹1,868 crore.
Total customer base crossed 5 million, though quarterly acquisitions dipped 18% to 78,000.
EBITDA rose 23% QoQ to ₹187 million, reflecting improved operational efficiency.
💼 Action for Investors
Investors should monitor the long-term impact of SEBI's derivative regulations on volumes, though the current recovery in ADTO and 30% PAT growth are strong positive signals. The shift towards 93% DIY onboarding and expansion of the MTF stock universe to 1,200+ names suggests a focus on higher-margin revenue streams.
5paisa Q3 FY26 PAT Drops 24% YoY to ₹12.3 Cr; Sequential Recovery of 29.7% Noted
5paisa Capital reported a 24% year-on-year decline in Profit After Tax (PAT) to ₹12.3 crore for the quarter ended December 31, 2025, largely due to lower fee and commission income. However, the company showed a strong sequential recovery, with PAT rising 29.7% compared to the September 2025 quarter. Total income for the quarter stood at ₹79.3 crore, down from ₹85.3 crore in the previous year. The company also strengthened its leadership by appointing new heads for HR, Investing Product, and Design.
Key Highlights
Consolidated PAT stood at ₹1,229.96 lacs, down 24% YoY but up 29.7% sequentially from ₹948.17 lacs.
Total Revenue from operations declined to ₹7,927.50 lacs from ₹8,526.70 lacs in the year-ago period.
Fees and commission income dropped significantly to ₹4,455.14 lacs from ₹5,405.33 lacs YoY.
Operating margin for the nine-month period was reported at 19% with a net profit margin of 14%.
Company disclosed ongoing regulatory matters including a SEBI show-cause notice regarding an expired Research Analyst License.
💼 Action for Investors
Investors should monitor the company's ability to stabilize its fee-based income amidst high competition and track the outcome of the SEBI and Income Tax proceedings. While the sequential growth is encouraging, the YoY decline suggests pressure on the core brokerage business.
5Paisa Q3 FY26 PAT Drops 24% YoY to ₹12.3 Cr; Revenue Declines to ₹79.3 Cr
5Paisa Capital reported a weak performance for Q3 FY26, with consolidated revenue from operations declining 7% YoY to ₹79.28 crore. Net profit for the quarter fell significantly by 24% YoY to ₹12.30 crore, down from ₹16.18 crore in the same period last year. For the nine-month period ending December 2025, the company's PAT saw a sharp decline to ₹33.33 crore compared to ₹58.17 crore in the previous year. The company is also navigating regulatory challenges, including a SEBI show cause notice regarding an expired research license and ongoing Income Tax proceedings.
Key Highlights
Consolidated Revenue from operations fell to ₹79.28 crore in Q3 FY26 from ₹85.27 crore in Q3 FY25.
Net Profit (PAT) for the quarter declined 24% YoY to ₹12.30 crore with Basic EPS dropping to ₹3.94.
9-month FY26 PAT stands at ₹33.33 crore, a significant drop from ₹58.17 crore in 9M FY25.
Company reported an Operating Margin of 19% and a Net Profit Margin of 14% for the period.
Disclosed ongoing regulatory matters including a SEBI Show Cause Notice for an expired Research Analyst License and an Income Tax search follow-up.
💼 Action for Investors
Investors should exercise caution as both top-line and bottom-line growth have decelerated significantly compared to the previous year. The pending regulatory outcomes from SEBI and the Income Tax department remain key monitorables that could impact future valuations.